Citation tools
"Anti-GPA33 Pretargeted Radioimmunotherapy (PRIT) of Colorectal Cancer (CRC) Using a Self-Assembling and Dis-Assembling (SADA) Bispecific Antibody to deliver 177Lu-Bivalent Benzyl-DOTA." Journal of Nuclear Medicine
65.supplement 2
(2024):
241233.
Web. 26 April. 2025.